Munich, Germany, 24 January, 2011. WILEX AG (ISIN DE0006614720 / WL6 / Frankfurt Stock Exchange) today announced the achievement of a major clinical milestone. Over 340 recurrences have now been …
News
Evotec AG – Collaboration with Takeda Cambridge for Multi-target Hit Identification
Hamburg, Germany - 20 January 2011: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced that it has entered into a collaboration with Takeda Cambridge Limited, to identify small molecule …
James E. Shipley, M.D., Named Chief Medical Officer of Concert Pharmaceuticals
Additional Management Team Announcement with Promotion of Robert Silverman January 19, 2011, Lexington, MA -- Concert Pharmaceuticals, Inc. announced today the appointment of James E. Shipley, M.D., …
Precision Therapeutics Announces New Study on Multi-Gene Predictors at 2010 San Antonio Breast Cancer Symposium
PITTSBURGH, Jan. 17, 2011 /PRNewswire/ -- In a new study in which Precision Therapeutics' Multi-Gene Predictors (MGPs) were independently validated by investigators at US Oncology and MD Anderson, …
New Patents Continue to issue for Concert Pharmaceuticals Deuterium Chemistry Intellectual Property
January 13, 2011 Lexington, MA –- Concert Pharmaceuticals, Inc. announced the issuance of several new patents relating to specific compounds derived from its DCE Platform™ (Deuterated Chemical Entity …
Anchor Therapeutics Achieves Milestone in GPCR Collaboration
-- Significant Progress Over First Four Months of Joint Research -- Cambridge, MA - January 7, 2011 - Anchor Therapeutics today announced that it has successfully completed the first stage of its …